On Friday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) was 9.36% up from the session before settling in for the closing price of $1.71. A 52-week range for SLS has been $0.77 – $2.27.
During the last 5-year period, the sales growth of Healthcare Sector giant was 45.94%. When this article was written, the company’s average yearly earnings per share was at 41.33%. With a float of $103.11 million, this company’s outstanding shares have now reached $105.30 million.
SELLAS Life Sciences Group Inc (SLS) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SELLAS Life Sciences Group Inc stocks. The insider ownership of SELLAS Life Sciences Group Inc is 2.08%, while institutional ownership is 25.58%. The most recent insider transaction that took place on Jun 12 ’25, was worth 14,800. In this transaction Director of this company bought 10,000 shares at a rate of $1.48, taking the stock ownership to the 20,400 shares. Before that another transaction happened on May 30 ’25, when Company’s Director bought 20,000 for $1.69, making the entire transaction worth $33,800. This insider now owns 30,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 41.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
You can see what SELLAS Life Sciences Group Inc (SLS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.36 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Looking closely at SELLAS Life Sciences Group Inc (NASDAQ: SLS), its last 5-days average volume was 2.94 million, which is a jump from its year-to-date volume of 2.5 million. As of the previous 9 days, the stock’s Stochastic %D was 79.02%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 56.10%, which indicates a significant decrease from 97.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1035 in the past 14 days, which was lower than the 0.1316 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7234, while its 200-day Moving Average is $1.4797. However, in the short run, SELLAS Life Sciences Group Inc’s stock first resistance to watch stands at $1.9321. Second resistance stands at $1.9941. The third major resistance level sits at $2.1102. If the price goes on to break the first support level at $1.7540, it is likely to go to the next support level at $1.6379. Should the price break the second support level, the third support level stands at $1.5759.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
There are 105,297K outstanding shares of the company, which has a market capitalization of 196.91 million. As of now, sales total 0 K while income totals -30,880 K. Its latest quarter income was 0 K while its last quarter net income were -6,600 K.
